trump medicare glp 1 says Medicare, Medicaid won't cover weight loss drugs GLP-1 weight loss drugs will

The continuous use approach represents traditional treatment strategy where daily GHK-Cu application continues indefinitely or until goals achieved, then potentially reduces to maintenance frequency (every other day or few times weekly) rather than complete discontinuation

This often requires less time than normal

Zhang M, Han W, Hu S, Xu H

Mojsov S, Heinrich G, Wilson IB, Ravazzola M, Orci L, Habener JF

Need To Know Info Additional Info Appointment required

Other considerations include hypoglycemia (most common concern), possible local tissue effects at injection sites, unknown long-term consequences of repeated local IGF-1 surges, and potential for organ growth with chronic use near specific organs